A confidential, structured path to close.
A successful healthcare transaction requires preparation, discretion and active coordination. Aligna manages the brokerage process from initial strategy through closing while working alongside the parties' professional advisors.
Confidential Consultation
We learn about the business, the owner's objectives, timing and confidentiality concerns. We review the general transaction landscape and determine what information is needed to evaluate marketability.
Valuation & Strategy
We review relevant financial and operational information, identify appropriate adjustments where applicable, assess the factors buyers are likely to focus on and establish a pricing and marketing strategy.
Confidential Marketing
We prepare a blind teaser and detailed marketing materials and introduce the opportunity through targeted outreach and Aligna's healthcare buyer relationships. Confidential information is released only through controlled disclosure.
Buyer Matching & Offers
We qualify interested parties, coordinate information flow, facilitate discussions and help the seller evaluate offers based on price, financing, structure, contingencies, timing and likelihood of closing.
Due Diligence & Close
Once an offer is accepted, we coordinate information and communication through diligence and closing and work alongside legal, accounting, escrow, regulatory and other advisors as required by the transaction.
Protecting the business while it is on the market.
Employees, patients, referral sources, competitors and vendors often do not need to know that a sale is being considered. The process is structured to limit unnecessary exposure while still providing qualified buyers with the information they need.
Blind Marketing
Initial marketing can exclude the business name and other identifying details while giving qualified buyers enough information to evaluate preliminary interest.
NDA-Controlled Disclosure
Detailed information is provided only after appropriate confidentiality agreements and buyer qualification.
Staged Information Release
Sensitive information can be released progressively as a buyer demonstrates genuine interest and moves deeper into the process.
Buyer Qualification
Before substantial confidential information is released, Aligna evaluates buyer seriousness, acquisition criteria and financial capability where appropriate.
Every transaction has its own timeline.
Timing can vary significantly based on the business, buyer, financing, diligence, purchase structure, licensing or regulatory requirements, real estate, third-party approvals and other closing conditions. We establish a practical transaction timeline once we understand the specific business and proposed structure.
Start with a confidential conversation.
No obligation and no commitment to sell — just a practical discussion about your business, your goals and the current market.